Editorial: Innovative Biologics and Drugs to Target Renal Inflammation

• Matthew D. Griffin,
• Sundararaman Swaminathan

Affiliations

Matthew D. Griffin

Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre, National University of Ireland Galway, Galway, Ireland

Sundararaman Swaminathan

Division of Nephrology, University of Virginia Health System, Charlottesville, VA, United States